Immunohematology Market Forecast and Insights: Exploring Growth Trends, Market Size, and Emerging Opportunities
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What External and Internal Drivers Are Contributing to the Growth of theImmunohematology Market?
The increase in hematological disease incidence is predicted to stimulate the expansion of the immunohematology market. Hematological disorders, which affect blood and its components such as red and white blood cells, platelets, and plasma, feature a wide range of conditions. Essential for successful and safe blood transfusions, immunohematology aids in averting transfusion reactions triggered by mismatched blood types or recipient antibodies. Additionally, immunohematology methods diagnose and treat diseases connected to the immune system that potentially influence the hematological system. For example, Cancer Research UK, a British research institution, anticipates the average leukemia cases caused by hematological disorders to increase from roughly 12,400 cases in 2023-2025 to approximately 14,500 cases in 2038-2040 in the UK. Consequently, the surge in hematological disorder incidence is fuelling the immunohematology market’s growth.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp
#How Does the ProjectedImmunohematology Market Growth Compare Over the Forecast Period?
Over recent years, the immunohematology market’s size has seen a consistent increase. Projected growth indicates an increase from $2.46 billion in 2024 to $2.57 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 4.6%. This historical growth trajectory has been propelled by factors including advancements in blood transfusion science, the commonality of blood disorders, the growth of blood banks, government measures ensuring blood safety, a rise in surgical procedures, and heightened awareness about the risks associated with transfusions.
The immunohematology market is set to experience notable expansion in the coming years, predicted to reach $3.24 billion in 2029, with a compound annual growth rate (CAGR) of 5.9%. This projected growth within the forecast period can be traced back to factors such as the growing need for point-of-care testing, the introduction of new blood products, enhancement of healthcare infrastructure, the application of genetic testing in determining blood compatibility, and regulatory policies promoting blood safety. Key trends for this forecast period are the adoption of automation and high-throughput systems, advancements in molecular blood typing procedures, improved antibody detection methods, the implementation of patient blood management programs, and the incorporation of artificial intelligence in analysis and telemedicine.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10295
Which Upcoming Market Trends and Innovations Are Set to Influence theImmunohematology Market’s Path Forward?
Top-tier firms in the immunohematology sector are honing in on innovating diagnostic solutions, such as soluble recombinant proteins, to counteract the interference from the cancer treatment daratumumab. Soluble recombinant proteins are proteins synthesized via recombinant DNA technology, which remain correctly folded and functional in a host cell or solution, making them versatile in research and therapeutic applications. For example, in November 2023, Grifols, S.A., a pharmaceutical corporation based in Spain, introduced the Grifols sCD38 solution. Grifols’ sCD38 stands as the pioneering soluble recombinant protein. This solution was devised to tackle the obstructions posed by daratumumab during critical blood transfusion compatibility tests. Tailored specifically for patients with multiple myeloma, this innovative solution prevents daratumumab from binding to CD38 proteins on the surface of red blood cells, thereby assuring accurate pre-transfusion test results. By streamlining the screening, identification, and crossmatching processes, Grifols sCD38 improves blood transfusion procedures and reduces potential delays in crucial transfusion provision.
Who Are the Dominant Market Players Pushing the Boundaries of theImmunohematology Market?
Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report
#thebusinessresearchcompany #marketresearch #marketintelligence
The immunohematology market covered in this report is segmented –
1) By Product: Analyzers And Systems, Reagents
2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)
3) By Disease: Blood-Related Diseases, HIV, Hepatitis
4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology
5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes
Subsegments:
1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems
2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp
What Regions Are Dominating the Immunohematology Market Growth?
North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Gobal Immunohematology Maret 2025, By The Business Research Company:
Out-of-Home Advertising Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/out-of-home-advertising-global-market-report
Advertising Agencies Global Market Opportunities And Strategies To 2031: COVID-19 Impact And Recovery
https://www.thebusinessresearchcompany.com/report/advertising-agencies-market
Print Advertising Distribution Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
